New lung support device shows promise for ARDS patients

NCT ID NCT04617093

Completed Disease control Sponsor: Vantive Health LLC Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 34 times

Summary

This study tested a device called PrismaLung+ that removes carbon dioxide from the blood, allowing doctors to use gentler breathing machine settings in patients with mild to moderate acute respiratory distress syndrome (ARDS). 63 adults on ventilators were enrolled. The main goals were to see if the device could safely enable ultra-protective lung ventilation and to track any side effects like bleeding.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MILD TO MODERATE ACUTE RESPIRATORY DISTRESS SYNDROME are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Investigational Site

Besançon, 25030, France
Investigational Site

Colombes, 92700, France
Investigational Site

Créteil, 94010, France
Investigational Site

Lille, 59037, France
Investigational Site

Marseille, 13354, France
Investigational Site

Montpellier, 34295, France
Investigational Site

Paris, 75013, France
Investigational Site

Paris, 75651, France
Investigational Site

Strasbourg, 67098, France
Investigational Site

Vandœuvre-lès-Nancy, 54511, France

Conditions

Explore the condition pages connected to this study.

MILD TO MODERATE ACUTE RESPIRATORY DISTRESS SYNDROME